LimFlow is a pioneering brand in the field of chronic limb-threatening ischemia (CLTI) treatment. When all other treatment options have been exhausted, LimFlow offers a ray of hope by providing a specialized procedure that aims to restore blood flow to the ischemic foot. The LimFlow Procedure is dedicated to giving patients once without hope a new lease on life.

The LimFlow System is a revolutionary medical device developed by LimFlow SA. Although it is currently an investigational device, it has received approval for sale in markets regulated by the CE Mark. It is essential to note that it is still limited by federal law to investigational use.

LimFlow is renowned for its commitment to clinical excellence and advancing the understanding and treatment of CLTI. With a team of dedicated professionals, LimFlow seeks to deliver innovative solutions that improve patients' quality of life. For more information about LimFlow, their products, or to stay up to date with the latest clinical evidence and news, please visit their official website